Oscient Pharmaceuticals Corporation
1000 Winter Street, Suite 2200
Waltham
Massachusetts
02451
United States
Tel: 781-398-2300
Fax: 781-893-9535
Website: http://www.oscient.com/
125 articles about Oscient Pharmaceuticals Corporation
-
Nanotherapeutics Acquires Two Late Stage Clinical Programs for Alzheimer's Treatment and CDA Disease From Oscient Pharmaceuticals Corporation And EPIX Pharmaceuticals, Inc.
12/16/2009
-
Oscient Pharmaceuticals Corporation Files for Bankruptcy; Sell its Antibiotic Drug Factive to Cornerstone Therapeutics Inc. Unit for $5 Million
7/14/2009
-
Oscient Pharmaceuticals Corporation to Cut Sales Force
6/12/2009
-
Oscient Pharmaceuticals Corporation Receives NASDAQ Letter Regarding Delay in Filing Form 10-Q
5/26/2009
-
Oscient Pharmaceuticals Corporation Reports Fourth Quarter and Full Year 2008 Financial Results
3/25/2009
-
Oscient Pharmaceuticals Corporation Gets Going Concern Notice; Looking at Alternative Including Sale of Company
3/25/2009
-
NASDAQ Extends Temporary Suspension of Bid Price and Market Value of Publicly Held Shares Requirements; Oscient Pharmaceuticals Corporation Compliance Period Extended to October 6, 2009
3/24/2009
-
Oscient Pharmaceuticals Corporation Restructures Commercial Organization; Reduces Workforce by 32%
2/12/2009
-
Oscient Pharmaceuticals Corporation Extends Maturity of its Privately Placed 5% Convertible Promissory Notes
1/29/2009
-
NASDAQ Extends Temporary Suspension of Bid Price and Market Value of Publicly Held Shares Requirements; Oscient Pharmaceuticals Corporation Compliance Period Extended to July 6, 2009
12/23/2008
-
Oscient Pharmaceuticals Corporation Announces Management Change
12/17/2008
-
Oscient Pharmaceuticals Corporation Receives Paragraph IV Certification Notice for ANTARA
12/3/2008
-
Massachusetts Biotechnology Council, Inc. Release: 19 Biotech Companies Selected to Present at 10th Annual MassBio Investors Forum
12/2/2008
-
Oscient Pharmaceuticals Corporation Announces Successful Completion of Convertible Debt Exchange Offer
11/24/2008
-
Oscient Pharmaceuticals Corporation Announces Determination of the Consideration Issuable in its Exchange Offer
11/20/2008
-
Oscient Pharmaceuticals Corporation to Participate in the Lazard Capital Markets 5th Annual Healthcare Conference
11/14/2008
-
Oscient Pharmaceuticals Corporation Amends Exchange Offer
11/7/2008
-
Oscient Pharmaceuticals Corporation to Participate in the Rodman & Renshaw 10th Annual Healthcare Conference
11/6/2008
-
Oscient Pharmaceuticals Corporation Reports Third Quarter 2008 Financial Results
11/4/2008
-
Webcast Alert: Oscient Pharmaceuticals Corporation Announces Date for Release of Third Quarter Financial Results
10/29/2008